Danger Triangle of Face and Septic Cavernous Sinus Thrombosis

J Emerg Med. 2017 Jul;53(1):137-138. doi: 10.1016/j.jemermed.2017.03.016. Epub 2017 Apr 10.

Authors

Ashok Kumar Pannu¹, Atul Saroch¹, Navneet Sharma¹

Affiliation

¹ Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 28408235
DOI: 10.1016/j.jemermed.2017.03.016

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Cavernous Sinus Thrombosis / diagnostic imaging*
Cavernous Sinus Thrombosis / drug therapy
Cavernous Sinus Thrombosis / etiology*
Ceftriaxone / therapeutic use
Drug Therapy, Combination
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Sepsis / complications*
Sepsis / diagnostic imaging
Sepsis / drug therapy*
Vancomycin / therapeutic use

Substances

Anti-Bacterial Agents
Heparin, Low-Molecular-Weight
Vancomycin
Ceftriaxone